RecruitingNCT05008081

The CATALINA Study

An International Multi-centre Prospective Cohort Study in Patients Hospitalized for an Acute Exacerbation of COPD


Sponsor

Wim Janssens

Enrollment

1,000 participants

Start Date

Oct 25, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The CATALINA study is a prospective cohort study embedded within CICERO (Collaboration In COPD ExaceRbatiOns, a European Respiratory Society supported Clinical Research Collaboration), designed to collect standardised, longitudinal clinical data and biological samples in 20 centres across Europe and beyond.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study (called CATALINA) looks at how to best monitor and manage patients who are hospitalized with an acute worsening (flare-up) of COPD — a lung disease that makes it hard to breathe. The study aims to identify better ways to treat these episodes and prevent future hospitalizations. **You may be eligible if...** - You are 18 or older with a confirmed diagnosis of COPD - You are currently hospitalized with a suspected acute flare-up (worsening) of COPD - You were included in the study within 48 hours of hospital admission **You may NOT be eligible if...** - You do not need antibiotics or steroids as treatment for this flare-up - You have tested positive for COVID-19 or are strongly suspected of having it - You are unwilling or unable to follow the study procedures Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(18)

Kepler University Hospital

Linz, Austria

CHU St-Pierre Brussels

Brussels, Belgium

UZ Leuven

Leuven, Belgium

CHU UCL Namur Site Godinne

Yvoir, Belgium

CHU de Lille

Lille, France

Cochin Hospital

Paris, France

LungenClinic

Großhansdorf, Germany

Klinikum Itzehoe

Itzehoe, Germany

University Medical Centre of Gießen & Marburg

Marburg, Germany

University Hospital of Ferrara

Ferrara, Italy

UMC Groningen

Groningen, Netherlands

Maastricht University Medical Hospital

Maastricht, Netherlands

Hospital Clinic de Barcelona

Barcelona, Spain

Sahlgrenska University Hospital

Gothenburg, Sweden

Glenfield Hospital

Leicester, United Kingdom

Guy's Saint Thomas

London, United Kingdom

Royal Brompton Hospital

London, United Kingdom

Churchil Hospital

Oxford, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05008081


Related Trials